Pharma Mar S.A. (PHMMF)
Company Description
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally.
The company operates through three segments: Oncology, Diagnostics, and RNA interference.
It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer.
The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors.
In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression.
The company was incorporated in 1986 and is based in Madrid, Spain.
| Country | ES |
| IPO Date | Feb 23, 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 500 |
| CEO | Jose Maria Fernandez Sousa-Faro Ph.D. |
Contact Details
Address: Avenida de los Reyes, 1 Madrid, ES | |
| Website | https://www.pharmamar.com |
Stock Details
| Ticker Symbol | PHMMF |
| Exchange | PNK |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | ES0169501022 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Jose Maria Fernandez Sousa-Faro Ph.D. | Founder, Executive Chairman, Chief Executive Officer & President |
| María Luisa de Francia Caballero | Chief Financial Officer |
| Belén Sopesén Veramendi Ph.D. | Director of Corporate Development |
| José Luis Moreno Martinez-Losa | Head of Capital Markets & Investor Relations |
| Juan Carlos-Torres Carretero | Founder |
| Juan Gomez Pulido | General Counsel & Secretary of the Board of Directors |
| Lara Vadillo | Communication Director |
| Luis Rupérez Cuenca | Director of Human Resources & IT |
| Pedro Francisco Fernandez Puentes | Executive Vice-Chairman |
| Sandra Llamera Sanchez | Global Compliance Head |